UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience

Leukemia & lymphoma, 2019-07, Vol.60 (9), p.2223-2229

2019

Volltextzugriff (PDF)

Dupilumab for Refractory Sclerotic-type Cutaneous Graft-versus-host Disease

Journal of the European Academy of Dermatology and Venereology, 2023-11, Vol.37 (11), p.e1323-e1324

2023

Volltextzugriff (PDF)

Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance

Transplantation and cellular therapy, 2024-07, Vol.30 (7), p.663-680

2024

Volltextzugriff (PDF)

Association of post-transplant outcomes with induction intensity in patients with acute myeloid leukemia

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19026-e19026

2021

Volltextzugriff (PDF)

Oral precancerous and malignant lesions associated with graft-versus-host disease: Report of 2 cases

Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 2002-01, Vol.93 (1), p.75-80

2002

Volltextzugriff (PDF)

High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation

Biology of blood and marrow transplantation, 2006, Vol.12 (1), p.61-67

2006

Volltextzugriff (PDF)

A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.561-566

2017

Volltextzugriff (PDF)

The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma

Bone marrow transplantation (Basingstoke), 2014-10, Vol.49 (10), p.1323-1329

2014

Volltextzugriff (PDF)

Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients

Bone marrow transplantation (Basingstoke), 2018-11, Vol.53 (11), p.1418-1427

2018

Volltextzugriff (PDF)

Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.913-916

2019

Volltextzugriff (PDF)

Impact of Cytokine Release Syndrome on Outcomes after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.3357-3357

2018

Volltextzugriff (PDF)

Psychosocial Risk Is Associated with High Readmission Rates and Increased Length of Stay for Patients Following Hematopoietic Stem Cell Transplantation

Blood, 2016-12, Vol.128 (22), p.1241-1241

2016

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(13)

Sprache

Englisch
(13)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Hematology
(7)
Immunology
(6)
Transplantation
(6)
Oncology
(5)
Adult
(4)
Biophysics
(4)
Bone Marrow
(4)
Humans
(4)
Adolescent
(3)
Hematopoietic Stem Cell Transplantation - Methods
(3)
Hematopoietic Stem Cells
(3)
Male
(3)
Middle Aged
(3)
Stem Cell Transplantation
(3)
Aged
(2)
Autografts
(2)
Biological And Medical Sciences
(2)
Female
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience

Dupilumab for Refractory Sclerotic-type Cutaneous Graft-versus-host Disease

Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance

Association of post-transplant outcomes with induction intensity in patients with acute myeloid leukemia

Oral precancerous and malignant lesions associated with graft-versus-host disease: Report of 2 cases

High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation

A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation

The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma

Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients

Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?

Impact of Cytokine Release Syndrome on Outcomes after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Response Rates, Non-Relapse Mortality, and Financial Implications of Transplant-Associated Thrombotic Microangiopathy Treated with Eculizumab

Psychosocial Risk Is Associated with High Readmission Rates and Increased Length of Stay for Patients Following Hematopoietic Stem Cell Transplantation

Suchergebnisse filtern